CIK 0001123494
- Non-accelerated filer
- Smaller reporting company
HARVARD BIOSCIENCE INC
Sign in to watch- Ticker
- HBIO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043306140
- Phone
- +1 508-893-8999
- Business address
- 84 OCTOBER HILL RD, HOLLISTON, MA, 01746
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $4.38 ($109,500)
- 4 Shares withheld for taxes Chief Executive Officer gave up 48,373 shares (to pay taxes)
- 4 Grant or award Director acquired 25,554 shares (grant or award)
- 4 Grant or award Director acquired 25,554 shares (grant or award)
- 4 Grant or award Director acquired 25,554 shares (grant or award)
- 4 Grant or award Director acquired 31,516 shares (grant or award)
- 4 Open-market buy Director bought 30,000 shares at an average $2.64 ($79,290)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $2.64 ($105,400)
- 4 Grant or award Chief Executive Officer acquired 692,750 shares (grant or award)
- 4 Grant or award Interim CFO acquired 82,634 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,960 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 125,509 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 30,000 shares at an average $2.51 ($75,300)
- 4 Other disposition Director disposed of 108,715 shares (other)
- 4 Open-market buy Director bought 9,291 shares at $3.41 ($31,682)
- 4 Open-market buy Director bought 25,535 shares at an average $3.27 ($83,385)
- 4 Open-market buy Director bought 13,857 shares at an average $3.21 ($44,414)
- 4 Open-market buy Director bought 10,759 shares at an average $3.27 ($35,186)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $3.19 ($127,600)
Page 3 of 32 · 623 filings